RBC Capital raised the firm’s price target on UnitedHealth (UNH) to $655 from $595 and keeps an Outperform rating on the shares ahead of the 2024 investor day. UnitedHealth’s 2025 guidance expectations are reasonably well set following Q3 earnings, which point to modest 8% EPS growth and flattish medical cost ratio for the initial guide, the analyst tells investors in a research note. The firm sees the potential for a more favorable Medicare backdrop under the new presidential administration.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on UNH:
- Trump Weekly: Trump looks to drop EV tax credit, fuel-efficiency requirements
- Trump Trade: Transition team weighing White House crypto role
- CVS (NYSE:CVS), UnitedHealth and Cigna File Suit Against the Federal Trade Commission
- Kennedy Jr. considers upheaval to U.S. Medicare billing system, FT says
- Trump Trade: Apollo CEO to be interviewed for Treasury Secretary role